Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes

Cristian Lasagna Reeves, Maxime W C Rousseaux, Marcos J. Guerrero-Munoz, Luis Vilanova-Velez, Jeehye Park, Lauren See, Paymaan Jafar-Nejad, Ronald Richman, Harry T. Orr, Rakez Kayed, Huda Y. Zoghbi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Previously, we reported that ATXN1 oligomers are the primary drivers of toxicity in Spinocerebellar ataxia type 1 (SCA1; Lasagna-Reeves et al., 2015). Here we report that polyQ ATXN1 oligomers can propagate locally in vivo in mice predisposed to SCA1 following intracerebral oligomeric tissue inoculation. Our data also show that targeting these oligomers with passive immunotherapy leads to some improvement in motor coordination in SCA1 mice and to a modest increase in their life span. These findings provide evidence that oligomer propagation is regionally limited in SCA1 and that immunotherapy targeting extracellular oligomers can mildly modify disease phenotypes.

Original languageEnglish (US)
Article numbere10891
JournaleLife
Volume4
Issue numberDECEMBER2015
DOIs
StatePublished - Dec 17 2015
Externally publishedYes

Fingerprint

Immunization
Spinocerebellar Ataxias
Passive Immunization
Pathology
Oligomers
Phenotype
Immunotherapy
Toxicity
Ataxin-1
Tissue

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lasagna Reeves, C., Rousseaux, M. W. C., Guerrero-Munoz, M. J., Vilanova-Velez, L., Park, J., See, L., ... Zoghbi, H. Y. (2015). Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes. eLife, 4(DECEMBER2015), [e10891]. https://doi.org/10.7554/eLife.10891

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes. / Lasagna Reeves, Cristian; Rousseaux, Maxime W C; Guerrero-Munoz, Marcos J.; Vilanova-Velez, Luis; Park, Jeehye; See, Lauren; Jafar-Nejad, Paymaan; Richman, Ronald; Orr, Harry T.; Kayed, Rakez; Zoghbi, Huda Y.

In: eLife, Vol. 4, No. DECEMBER2015, e10891, 17.12.2015.

Research output: Contribution to journalArticle

Lasagna Reeves, C, Rousseaux, MWC, Guerrero-Munoz, MJ, Vilanova-Velez, L, Park, J, See, L, Jafar-Nejad, P, Richman, R, Orr, HT, Kayed, R & Zoghbi, HY 2015, 'Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes', eLife, vol. 4, no. DECEMBER2015, e10891. https://doi.org/10.7554/eLife.10891
Lasagna Reeves, Cristian ; Rousseaux, Maxime W C ; Guerrero-Munoz, Marcos J. ; Vilanova-Velez, Luis ; Park, Jeehye ; See, Lauren ; Jafar-Nejad, Paymaan ; Richman, Ronald ; Orr, Harry T. ; Kayed, Rakez ; Zoghbi, Huda Y. / Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes. In: eLife. 2015 ; Vol. 4, No. DECEMBER2015.
@article{2d26ea0ab5a946acb36b2758bf9807b7,
title = "Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes",
abstract = "Previously, we reported that ATXN1 oligomers are the primary drivers of toxicity in Spinocerebellar ataxia type 1 (SCA1; Lasagna-Reeves et al., 2015). Here we report that polyQ ATXN1 oligomers can propagate locally in vivo in mice predisposed to SCA1 following intracerebral oligomeric tissue inoculation. Our data also show that targeting these oligomers with passive immunotherapy leads to some improvement in motor coordination in SCA1 mice and to a modest increase in their life span. These findings provide evidence that oligomer propagation is regionally limited in SCA1 and that immunotherapy targeting extracellular oligomers can mildly modify disease phenotypes.",
author = "{Lasagna Reeves}, Cristian and Rousseaux, {Maxime W C} and Guerrero-Munoz, {Marcos J.} and Luis Vilanova-Velez and Jeehye Park and Lauren See and Paymaan Jafar-Nejad and Ronald Richman and Orr, {Harry T.} and Rakez Kayed and Zoghbi, {Huda Y.}",
year = "2015",
month = "12",
day = "17",
doi = "10.7554/eLife.10891",
language = "English (US)",
volume = "4",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",
number = "DECEMBER2015",

}

TY - JOUR

T1 - Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows spinocerebellar ataxia type 1 phenotypes

AU - Lasagna Reeves, Cristian

AU - Rousseaux, Maxime W C

AU - Guerrero-Munoz, Marcos J.

AU - Vilanova-Velez, Luis

AU - Park, Jeehye

AU - See, Lauren

AU - Jafar-Nejad, Paymaan

AU - Richman, Ronald

AU - Orr, Harry T.

AU - Kayed, Rakez

AU - Zoghbi, Huda Y.

PY - 2015/12/17

Y1 - 2015/12/17

N2 - Previously, we reported that ATXN1 oligomers are the primary drivers of toxicity in Spinocerebellar ataxia type 1 (SCA1; Lasagna-Reeves et al., 2015). Here we report that polyQ ATXN1 oligomers can propagate locally in vivo in mice predisposed to SCA1 following intracerebral oligomeric tissue inoculation. Our data also show that targeting these oligomers with passive immunotherapy leads to some improvement in motor coordination in SCA1 mice and to a modest increase in their life span. These findings provide evidence that oligomer propagation is regionally limited in SCA1 and that immunotherapy targeting extracellular oligomers can mildly modify disease phenotypes.

AB - Previously, we reported that ATXN1 oligomers are the primary drivers of toxicity in Spinocerebellar ataxia type 1 (SCA1; Lasagna-Reeves et al., 2015). Here we report that polyQ ATXN1 oligomers can propagate locally in vivo in mice predisposed to SCA1 following intracerebral oligomeric tissue inoculation. Our data also show that targeting these oligomers with passive immunotherapy leads to some improvement in motor coordination in SCA1 mice and to a modest increase in their life span. These findings provide evidence that oligomer propagation is regionally limited in SCA1 and that immunotherapy targeting extracellular oligomers can mildly modify disease phenotypes.

UR - http://www.scopus.com/inward/record.url?scp=84988638319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988638319&partnerID=8YFLogxK

U2 - 10.7554/eLife.10891

DO - 10.7554/eLife.10891

M3 - Article

C2 - 26673892

AN - SCOPUS:84988638319

VL - 4

JO - eLife

JF - eLife

SN - 2050-084X

IS - DECEMBER2015

M1 - e10891

ER -